Kota Nagai

Safety and efficacy of combination therapy of iguratimod with methotrexate for patients with active rheumatoid arthritis with an inadequate response to methotrexate: An open-label extension of a randomized, double-blind, placebo-controlled trial

Masako Hara, Naoki Ishiguro, Kou Katayama et al. · Modern Rheumatology · 2013 · 70 citations

Medicine, Clinical Sciences, Pharmacotherapy +14

Concomitant iguratimod therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate: a randomized, double-blind, placebo-controlled trial

Naoki Ishiguro, Kazuhiko Yamamoto, Kou Katayama et al. · Modern Rheumatology · 2013 · 56 citations

Medicine, Clinical Sciences, Pharmacotherapy +9

Concomitant iguratimod therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate: a randomized, double-blind, placebo-controlled trial

Naoki Ishiguro, Kazuhiko Yamamoto, Kou Katayama et al. · Modern Rheumatology · 2012 · 54 citations

Medicine, Clinical Sciences, Pharmacotherapy +9

Fully automated and highly specific plasma β-amyloid immunoassays predict β-amyloid status defined by amyloid positron emission tomography with high accuracy

Kazuto Yamashita, Masahiro Miura, Shunsuke Watanabe et al. · Alzheimer s Research & Therapy · 2022 · 49 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Estimating the cost‐effectiveness of screening for hepatitis C virus infection in Japan

Kota Nagai, Kazuki Ide, Yohei Kawasaki et al. · Hepatology Research · 2020 · 12 citations

Pharmacy, Pharmacoeconomics, Cost-effectiveness Analysis +16